AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Esophageal Pre-Cancer Testing Gaining Greater Traction
How three companies are addressing screening challenges with tests that help improve chances of early detection
Computing the Future of the Lab
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab
Cost Avoidance vs Cost Savings: What’s the Difference?
By Jennifer Dawson, MHA, DLM (ASCP) bio
As I work to spread awareness within the clinical laboratory community about the Cost of Poor Quality (COPQ) concept and its benefits as a method to demonstrate…
Targeted Sequencing Panel May Aid Diagnosis of Movement Disorders
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
FDA Issues Warning for ‘Over Reliance’ on Rupture of Membrane Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Mailed Kits Can Up Colorectal Screening at Community Health Clinics
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
With New FDA Input, Momentum for LDT Regulation Accelerating
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
High-Sensitivity Troponin Test Rules Out Heart Attacks Faster
From - Diagnostic Testing & Emerging Technologies
Use of a high-sensitivity cardiac troponin test (hs-cTnT) may be able to more quickly determine whether emergency department patients are having…
Whole-Genome Sequencing Adds Value to Cardiomyopathy Workup
From - Diagnostic Testing & Emerging Technologies
Whole-genome sequencing (WGS) identifies additional genetic causes of hypertrophic cardiomyopathy (HCM) beyond those identified through targeted…
Noninvasive Gene Expression Test for Melanoma Cuts Costs
From - Diagnostic Testing & Emerging Technologies
The noninvasive pigmented lesion assay (PLA; DermTech) reduces costs compared to the current standard of care for diagnostic workup of pigmented skin lesions suggestive of…
Next-Gen Sequencing Has Significant Utility for Drug-Resistant Epilepsy
From - Diagnostic Testing & Emerging Technologies
Next-generation sequencing improves definitive diagnoses for children with drug-resistant epilepsy, according to a pilot study published online…
General Population Has Interest in Genetic Testing for Skin Cancer Risk
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
